EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis of novel 1,2,4-oxadiazole-isoxazoline hybrids and their in silico potential with adenosine receptors

Pshtiwan S Mohammed iD, Mohammed K S Dalo, Onur C Yazıcı, Muhammet Yildirim iD, Akın Sağırlı

Beilstein Journal of Organic Chemistry · 06.07.2026 · 22 · 1033-1047

DOI: 10.3762/bjoc.22.82 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Beilstein Journal of Organic Chemistry, online erschienen am 06.07.2026. Verfasst von Pshtiwan S Mohammed und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, College of Sciences, Charmo University, Peshawa Street, Chamchamal, Sulaymaniyah, 46023, Iraq. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A concise and efficient synthetic route to novel 1,2,4-oxadiazole-isoxazoline hybrids 7 has been developed via regioselective 1,3-dipolar cycloaddition of in situ-generated nitrile oxides with 3-( p -substituted-aryl)-5-vinyl-1,2,4-oxadiazoles 6 . The target compounds 7a–ay were obtained in moderate to excellent yields (16–97%) and fully characterized by IR, NMR, and HRMS analyses. The reactions exhibited high regioselectivity, exclusively affording 5-isoxazoline derivatives, while substituent effects played a decisive role in modulating reaction efficiency. In silico studies revealed that all hybrids 7a–ay display strong binding affinities toward the adenosine A₁ receptor (−10.0 to −8.3 kcal/mol), surpassing the co-crystallized ligand and engaging in key stabilizing interactions within the binding pocket. Furthermore, ADMET predictions indicated favorable drug-likeness, high gastrointestinal absorption, and suitable physicochemical properties. Overall, these findings identify 1,2,4-oxadiazole-isoxazoline hybrids as promising and tunable scaffolds for the development of adenosine A₁ receptor-targeted agents; however, further structural optimization and comprehensive biological evaluation are required to fully validate their therapeutic potential.

Schlagwörter

Stichwörter der Autor:innen

1,2,4-oxadiazoles1,3-dipolar cycloadditionaldoximeantiparkinsonisoxazoline

Autor:innen und Institutionen

  • Department of Chemistry, College of Sciences, Charmo University, Peshawa Street, Chamchamal, Sulaymaniyah, 46023, Iraq.
  • Department of Pharmacy, Bright Technical and Vocational Institute, Sulaymaniyah, Kurdistan Region, 46001, Iraq.
  • Department of Chemistry, College of Sciences, Ibrahim Ahmed High School, Bardasur Street, Kalar, Sulaymaniyah, 46021, Iraq.
  • Department of Chemistry, Faculty of Arts and Sciences, Bolu Abant Izzet Baysal University, TR-14280, Bolu, Türkiye.

ORCID-Profile: Pshtiwan S Mohammed, Muhammet Yildirim

Zitieren

APA

Mohammed, P. S., Dalo, M. K. S., Yazıcı, O. C., Yildirim, M., & Sağırlı, A. (2026). Synthesis of novel 1,2,4-oxadiazole-isoxazoline hybrids and their in silico potential with adenosine receptors. Beilstein Journal of Organic Chemistry, 22, 1033-1047. https://doi.org/10.3762/bjoc.22.82

Vancouver

Mohammed PS, Dalo MKS, Yazıcı OC, Yildirim M, Sağırlı A. Synthesis of novel 1,2,4-oxadiazole-isoxazoline hybrids and their in silico potential with adenosine receptors. Beilstein Journal of Organic Chemistry. 2026;22:1033-1047. doi:10.3762/bjoc.22.82

BibTeX
@article{Mohammed2026,
  author = {Mohammed, Pshtiwan S and Dalo, Mohammed K S and Yazıcı, Onur C and Yildirim, Muhammet and Sağırlı, Akın},
  title = {Synthesis of novel 1,2,4-oxadiazole-isoxazoline hybrids and their in silico potential with adenosine receptors},
  journal = {Beilstein Journal of Organic Chemistry},
  year = {2026},
  volume = {22},
  pages = {1033--1047},
  doi = {10.3762/bjoc.22.82}
}
Kostenlos starten →